Abstract

Splicing of the adenovirus IIIa mRNA is subjected to a strict temporal regulation during virus infection such that efficient IIIa 3' splice site usage is confined to the late phase of the infectious cycle. Here we show that the adenovirus L4-33K protein functions as a virus-encoded RNA splicing factor that preferentially activates splicing of transcripts with a weak 3' splice site sequence context, a sequence configuration that is shared by many of the late adenovirus 3' splice sites. Furthermore, we show that L4-33K activates IIIa splicing through the IIIa virus infection-dependent splicing enhancer element (3VDE). This element was previously shown to be the minimal element, both necessary and sufficient, for activation of IIIa splicing in the context of an adenovirus-infected cell. L4-33K stimulates an early step in spliceosome assembly and appears to be the only viral protein necessary to convert a nuclear extract prepared from uninfected HeLa cells to an extract with splicing properties very similar to a nuclear extract prepared from adenovirus late-infected cells. Collectively, our results suggest that L4-33K is the key viral protein required to activate the early to late switch in adenovirus major late L1 alternative splicing.

Highlights

  • The accumulation of mRNA from the MLTU is subjected to a temporal regulation at the levels of transcription elongation, poly(A) site choice and alternative 3Ј splice site selection

  • We conclusively show that the L4-33K protein functions as a virus-encoded alternative RNA splicing factor that both in vivo and in vitro regulates alternative splicing

  • Previous work has identified two cis-acting elements which appear to be critical for the temporal regulation of IIIa 3Ј splice site usage (Fig. 1): the 49-nucleotide-long IIIa repressor element, which binds the SR family of splicing factors, and the 28-nucleotide-long IIIa virus infection-dependent splicing enhancer, which up to this study functioned by an unknown mechanism

Read more

Summary

Introduction

The accumulation of mRNA from the MLTU is subjected to a temporal regulation at the levels of transcription elongation, poly(A) site choice and alternative 3Ј splice site selection (reviewed in Ref. 1). Co-transfection of the L4-33K expressing plasmid, pcDNA3-L4-33K, resulted in a dose-dependent increase in IIIa mRNA accumulation (Fig. 2A, lanes 2– 6). Complementing the HeLa-NE with the recombinant L4-33K protein resulted in a significant activation of distal IIIa 3Ј splice site usage (lane 3).

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call